PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Dasiglucagon→

Dasiglucagon PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
1544300-84-6
Molecular formula
C152H222N38O50
Molecular weight
3381.61 g/mol
Drug class
Antihypoglycemic Agent
Mechanism of action
Glucagon Receptor Agonists
Indications / reported uses
  • Hypoglycemia
View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Dasiglucagon PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Dasiglucagon Permitted Daily Exposure (PDE) report (the Dasiglucagon PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Dasiglucagon Occupational Exposure Limit (OEL) report (the Dasiglucagon OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.